BSE Sensex climbed 358 points to 69,654 on December 6. Nifty50 jumped 83 points to 20,938, taking the total seven-day gains to 3,684 points and 1,143 points, respectively. It witnessed a consistent run-up for the last seven consecutive sessions. It formed a Dragonfly Doji kind of candlestick pattern along with a bearish crossover in hourly charts and increasing volatility
Key support and resistance levels on the Nifty
The pivot point calculator indicates that the Nifty is likely to see immediate resistance at 20,959, followed by 20,985 and 21,027. On the lower side, it can take support at 20,875 followed by 20,849 and 20,808 levels.
Key support and resistance levels on Nifty Bank
As per the pivot point calculator, the index is expected to see resistance at 47,143, followed by 47,263 and 47,458. On the lower side, it may take support at 46,754, followed by 46,633 and 46,439.
Wall Street ends lower as investors weigh fresh employment data
US stocks ended down on Wednesday, pulled lower by megacaps and energy shares. This was due to signs of a cooling jobs market which reinforced expectations that the Federal Reserve could start cutting interest rates early next year.
The S&P 500 declined 0.39% to end at 4,549.34 points. The Nasdaq Composite Index fell 0.58% to 14,146.71, while the Dow Jones Industrial Average slid 0.19% to 36,054.43.
Oil falls 4% as build in gasoline stocks fuel demand concerns
Oil prices fell nearly 4% on Wednesday to their lowest settlements since June. Worries about global fuel demand mounted after US data showed a larger-than-expected rise in gasoline inventories.
Brent crude futures settled down $2.90, or 3.8%, at $74.30 a barrel. US WTI crude futures fell by $2.94, or 4.1%, to $69.38 a barrel.
Stocks on the radar
IRCON International: The Government of India will be selling an 8 percent stake or 7.52 crore equity shares in the infrastructure company via offer-for-sale (OFS) on December 7-8, with a floor price of Rs 154 per share.
Dr Reddy’s Laboratories: Subsidiary Dr Reddy’s Laboratories SA and Coya Therapeutics Inc entered into a development and license agreement for the development and commercialisation of COYA 302, an investigational combination therapy for the treatment of Amyotrophic Lateral Sclerosis (ALS).
Bharat Electronics: The state-owned defence company has received an order of Rs 580 crore from the Indian Army for AMC of radars. It has also received additional orders worth Rs 3,335 crore since the last disclosure on September 15, 2023. With this, cumulatively BEL has received orders worth Rs 18,298 crore in FY24.
One 97 Communications: The Paytm operator will further expand its business to offer higher-ticket personal and merchant loans, which would be targeted at lower-risk and high credit-worthy customers, in partnership with large banks and NBFCs.
IDFC First Bank: Cloverdell Investment, an affiliate of global private equity firm Warburg Pincus is likely to sell a 1.3 percent stake in IDFC First Bank via a block deal, reports CNBC-TV18 quoting sources. The deal size may be around $100 million, with a floor price of Rs 85.7 per share.
FII and DII data
Foreign institutional investors (FIIs) turned net sellers for the first time in the last 10 consecutive sessions, offloading shares worth Rs 79.88 crore. Domestic institutional investors (DIIs) bought Rs 1,372.18 crore worth of stocks on December 6, data from NSE showed.
Stock under F&O ban on NSE
The NSE has added SAIL to its F&O ban list for December 7. It retained Delta Corp, Indiabulls Housing Finance, India Cements and Zee Entertainment Enterprises to the said list.
BSE, NSE GIFT City units to be merged by Jan 2024
The two operational international exchanges at GIFT City — BSE’s India INX and NSE’s International Exchange — will be merged by January end, said IFSCA chairperson K Rajaraman on December 6.
Disclaimer: The information provided in this blog post is for informational purposes only and should not be construed as investment or trading advice. The author is not a financial advisor and does not have any professional qualifications in this area. The author does not guarantee the accuracy or completeness of the information provided. Any action you take based on the information in this blog post is done at your own risk. Please consult with a financial advisor before making any investment decisions.
How useful was this post?
Click on a star to rate it!
Average rating 0 / 5. Vote count: 0
No votes so far! Be the first to rate this post.
Spread the love
Open Free Demat Account!
In just a few minutes, Simply provide some basic personal details, to get started.
As you are aware, under the rapidly evolving dynamics of financial markets, it is crucial for investors to remain updated and well-informed about various aspects of investing in the securities market. In this connection, please find a link to the BSE Investor Protection Fund website where you will find some useful educational material in the form of text and videos, so as to become an informed investor.